Pharma Monopoly: The Battle for the Future of Medicines w/ Tahir Amin

Pharma Monopoly: The Battle for the Future of Medicines w/ Tahir Amin

July 9, 2026 · 36 min · Episode 1167

About this episode

J.G. Michael discusses the implications of pharmaceutical monopolies with Tahir Amin, exploring the costs of medicines and the influence of patents and neoliberal policies.

👉 Pitch in on Patreon and fuel the future of free-thinking conversations. https://www.patreon.com/parallaxviews Also visit our returning sponsor Mike Swanson's Wall Street Window for the best financial and trading newsletter around:https://wallstreetwindow.com/ On this edition of Parallax Views, J.G. Michael is joined by Tahir Amin, founder and CEO of the Initiative for Medicines, Access & Knowledge (I-MAK) and co-author, with Rohit Malpani, of the new book Pharma Monopoly: The Battle for the Future of Medicines. Why have prescription drugs and life-saving medicines become so expensive? Is it simply the cost of innovation, or is the modern pharmaceutical industry built around monopoly power? In this brisk, information-packed conversation, Amin examines how patents, intellectual property law, global trade agreements, financialization, and neoliberal economic policies have reshaped the pharmaceutical industry and transformed medicine into one of the world's most profitable businesses. Drawing on the arguments in Pharma Monopoly, Amin explains how patent monopolies can delay generic competition, why the pharmaceutical industry's definition of "innovation" deserves closer…

Sponsors

Wall Street Window

More episodes of Parallax Views w/ J.G. Michael

Explore listener stats, chart rankings, contacts and more on the Parallax Views w/ J.G. Michael podcast page.